scholarly journals Anlotinib Combined with S‐1 in Third‐ or Later‐Line Stage IV Non‐Small Cell Lung Cancer Treatment: A Phase II Clinical Trial

2021 ◽  
Author(s):  
Miao Xiang ◽  
Xiyue Yang ◽  
Surong Ren ◽  
Fan Du ◽  
Lidan Geng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Cancer Treatment ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated

Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer

1996 ◽  
Vol 19 (4) ◽  
pp. 328-332 ◽  
Author(s):  
H.H. Fiebig ◽  
H. Henß ◽  
I. von Pawel ◽  
U. Gatzemeier ◽  
Ch. Manegold ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung ◽  
Pretreated Patients

A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-small cell lung cancer (NSCLC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2592-2592 ◽  
Author(s):  
A. Chatterjee ◽  
J. Biswas ◽  
A. K. Chatterjee ◽  
S. Bhattacharya ◽  
B. P. Mukhopadhyay ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Cancer Treatment ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document